Genomics, nanotech get bigger share of EU budget
This article was originally published in Clinica
Genomics, biotechnology and nanotechnology are among the priority areas of the European Union's R&D budget for 2002-2006. Genomics and biotechnology are to receive Euro2 billion ($1.82 billion) of the Euro16.27 billion available, with nanotechnologies and emerging technologies receiving a share of over Euro3.5 billion.
You may also be interested in...
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
FTC pursuing bogus health and other products or services capitalizing on Covid-19 fear with scams skyrocketing. However, FTC says its enforcement will consider whether businesses are making good faith efforts to produce products in high demand.
Warning letters show FDA's coronavirus investigations inthe consumer health marketplace didn't stop when it suspended facility inspections. The letters identify firms that previously marketed only bedding products as offering supplements with coronavirus claims or that are in other countries and are shipping to US consumers products promoted with coronavirus claims.